OrbiMed Genesis GP LLC insider trades: Electra Therapeutics (ETRA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where OrbiMed Genesis GP LLC reports to the SEC
and 19 more companies
Open-market buys and sales
73 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | ETRA | ↑ Buy | 472,571 | $7.63 | $3.6M | Indirect | Nov 5, 2026 (0d) |
| Sep 28, 2026 | ADRX | ↑ Buy | 950,000 | $17.00 | $16.1M | Indirect | Sep 30, 2026 (2d) |
| Sep 21, 2026 | ETRA | ↑ Buy | 1,333,333 | $15.00 | $20.0M | Indirect | Sep 23, 2026 (2d) |
| Aug 7, 2026 | BRVE | ↑ Buy | 1,940,000 | $18.00 | $34.9M | Indirect | Aug 11, 2026 (4d) |
| Jun 22, 2026 | ELVN | ↓ Sell | 860,123 | $45.36 | $39.0M | Indirect | Jun 24, 2026 (2d) |
| Jun 15, 2026 | ELVN | ↓ Sell | 281,408 | $45.02 | $12.7M | Indirect | Jun 17, 2026 (2d) |
| May 28, 2026 | QTTB | ↑ Buy | 1,875,000 | $8.00 | $15.0M | Indirect | Jun 1, 2026 (4d) |
| Apr 8, 2026 | ACET | ↓ Sell | 104,658 | $6.45 | $675K | Indirect | Apr 9, 2026 (1d) |
| Oct 8, 2025 | ACET | ↑ Buy | 5,000,000 | $1.00 | $5.0M | Indirect | Oct 10, 2025 (2d) |
| Aug 25, 2025 | STTK | ↑ Buy | 6,306,127 | $0.87 | $5.5M | Indirect | Sep 2, 2025 (8d) |
| Apr 9, 2025 | CMPX | ↓ Sell | 3,571,428 | $1.59 | $5.7M | Indirect | Apr 11, 2025 (2d) |
| Apr 3, 2025 | EWTX | ↑ Buy | 496,771 | $20.13 | $10.0M | Indirect | Apr 4, 2025 (1d) |
| Mar 24, 2025 | IRON | ↓ Sell | 5,738 | $54.11 | $310K | Indirect | Mar 26, 2025 (2d) |
| Mar 21, 2025 | IRON | ↓ Sell | 52,429 | $54.02 | $2.8M | Indirect | Mar 21, 2025 (0d) |
| Mar 12, 2025 | IRON | ↓ Sell | 312,384 | $54.31 | $17.0M | Indirect | Mar 12, 2025 (0d) |
| Feb 18, 2025 | MBX | ↑ Buy | 190,672 | $10.60 | $2.0M | Indirect | Feb 19, 2025 (1d) |
| Sep 16, 2024 | MBX | ↑ Buy | 500,000 | $16.00 | $8.0M | By OrbiMed Private Investments VII, LP | Sep 17, 2024 (1d) |
| Sep 16, 2024 | MBX | ↑ Buy | 250,000 | $16.00 | $4.0M | By OrbiMed Genesis Master Fund, L.P. | Sep 17, 2024 (1d) |
| Aug 13, 2024 | KROS | ↓ Sell | 250,000 | $44.01 | $11.0M | Indirect | Aug 15, 2024 (2d) |
| Aug 13, 2024 | SCPH | ↑ Buy | 500,000 | $4.00 | $2.0M | Indirect | Aug 15, 2024 (2d) |
| Jul 16, 2024 | TERN | ↓ Sell | 56,164 | $10.00 | $562K | Indirect | Jul 17, 2024 (1d) |
| Jun 17, 2024 | IRON | ↑ Buy | 83,334 | $36.00 | $3.0M | Indirect | Jun 20, 2024 (3d) |
| May 16, 2024 | ELVN | ↓ Sell | 1,033,300 | $22.14 | $22.9M | Indirect | May 20, 2024 (4d) |
| Jan 25, 2024 | ACET | ↑ Buy | 3,125,000 | $2.40 | $7.5M | Indirect | Jan 26, 2024 (1d) |
| Jan 23, 2024 | EWTX | ↑ Buy | 454,545 | $11.00 | $5.0M | Indirect | Jan 25, 2024 (2d) |
| Dec 28, 2023 | ALPN | ↓ Sell | 1,546,347 | $18.54 | $28.7M | Indirect | Dec 29, 2023 (1d) |
| Dec 18, 2023 | IRON | ↓ Sell | 1,724 | $59.24 | $102K | Direct | Dec 20, 2023 (2d) |
| Dec 14, 2023 | IRON | ↓ Sell | 433,200 | $56.75 | $24.6M | Indirect | Dec 15, 2023 (1d) |
| Dec 14, 2023 | IRON | ↓ Sell | 134,200 | $58.88 | $7.9M | Indirect | Dec 14, 2023 (0d) |
| Nov 22, 2023 | PMVP | ↓ Sell | 87,786 | $2.23 | $196K | Indirect | Nov 24, 2023 (2d) |
| Aug 15, 2023 | GLTO | ↓ Sell | 822,680 | $0.75 | $617K | Indirect | Aug 17, 2023 (2d) |
| Jul 31, 2023 | GLTO | ↓ Sell | 209,400 | $3.00 | $628K | Indirect | Aug 2, 2023 (2d) |
| Jul 25, 2023 | GLTO | ↓ Sell | 39,200 | $2.92 | $114K | Indirect | Jul 27, 2023 (2d) |
| Jul 17, 2023 | THRX | ↑ Buy | 479,932 | $3.05 | $1.5M | Indirect | Jul 19, 2023 (2d) |
| Jul 13, 2023 | GLTO | ↓ Sell | 194,700 | $2.40 | $467K | Indirect | Jul 17, 2023 (4d) |
| Jun 27, 2023 | ACET | ↑ Buy | 875,000 | $2.09 | $1.8M | Indirect | Jun 29, 2023 (2d) |
| May 5, 2023 | KNTE | ↑ Buy | 1,377,473 | $2.80 | $3.9M | Indirect | May 8, 2023 (3d) |
| May 2, 2023 | KNTE | ↑ Buy | 1,346,342 | $2.61 | $3.5M | Indirect | May 2, 2023 (0d) |
| Apr 17, 2023 | GLTO | ↓ Sell | 68,481 | $1.87 | $128K | Indirect | Apr 17, 2023 (0d) |
| Apr 12, 2023 | GLTO | ↓ Sell | 67,537 | $1.80 | $121K | Indirect | Apr 12, 2023 (0d) |
| Apr 6, 2023 | GLTO | ↓ Sell | 102,630 | $2.16 | $222K | Indirect | Apr 7, 2023 (1d) |
| Feb 15, 2023 | IRON | ↑ Buy | 108,696 | $23.00 | $2.5M | Indirect | Feb 17, 2023 (2d) |
| Dec 23, 2022 | TERN | ↑ Buy | 137,931 | $7.25 | $1000K | Indirect | Dec 28, 2022 (5d) |
| Nov 25, 2022 | SCPH | ↑ Buy | 762,380 | $5.25 | $4.0M | Indirect | Nov 29, 2022 (4d) |
| Nov 8, 2022 | CMPX | ↑ Buy | 402,000 | $3.21 | $1.3M | Indirect | Nov 10, 2022 (2d) |
| Nov 7, 2022 | THRX | ↑ Buy | 192,000 | $5.21 | $1.0M | Indirect | Nov 9, 2022 (2d) |
| Sep 16, 2022 | EWTX | ↑ Buy | 484,496 | $10.32 | $5.0M | Indirect | Sep 16, 2022 (0d) |
| Aug 16, 2022 | TERN | ↑ Buy | 3,690,000 | $2.42 | $8.9M | Indirect | Aug 18, 2022 (2d) |
| Jun 24, 2022 | IKNA | ↑ Buy | 252,225 | $4.47 | $1.1M | Indirect | Jun 24, 2022 (0d) |
| May 26, 2022 | PMVP | ↓ Sell | 26,253 | $15.93 | $418K | Indirect | May 31, 2022 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ETRA insiders
Open-market trades in the last 12 months
About OrbiMed Genesis GP LLC's insider trades
OrbiMed Genesis GP LLC is a director at Electra Therapeutics (ETRA). Since Apr 13, 2020, it has reported 46 open-market purchases worth $322.0M and 27 sales worth $197.6M on SEC Form 4. In the last 12 months: 5 buys ($89.7M) and 3 sales ($52.4M).
Its filings also include conversions (14 filings), other transactions (7 filings), grants and awards (7 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ETRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.